Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cells|March 29, 2023
HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)Tomasz Pawlowski, Krzysztof Malyszczak, Dariusz Pawlak, et al.
Clinical and Experimental Hepatology|December 19, 2024
Treatment of HCV infection in patients with steatotic liver diseaseRobert Flisiak, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, et al.
Polish Archives of Internal Medicine|January 5, 2023
Effectiveness of pangenotypic retreatment of chronic hepatitis C after prior failure of pangenotypic therapiesJerzy Jaroszewicz, Dorota Zarębska-Michaluk, Justyna Janocha-Litwin, et al.
Polish Archives of Internal Medicine|January 2, 2024
Treatment of the most difficult-to-cure hepatitis C virus-infected population with sofosbuvir / velpatasvirRobert Flisiak, Dorota Zarębska-Michaluk, Hanna Berak, et al.
Antiviral Research|November 9, 2023
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?Dorota Zarębska-Michaluk, Robert Flisiak, Ewa Janczewska, et al.
Journal of Clinical Medicine|January 10, 2026
Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver TransplantationMichał Brzdęk, Dorota Zarębska-Michaluk, Olga Tronina, et al.
Polish Archives of Internal Medicine|April 14, 2026
Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?Kinga Brzdęk, Dorota Zarębska-Michaluk, Beata Lorenc, et al.
Viruses|April 3, 2021
Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19Monika Maria Biernat, Anna Kolasińska, Jacek Kwiatkowski, et al.
BMC Medicine|October 24, 2024
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationDorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, et al.
Journal of Clinical Medicine|October 13, 2021
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort StudyElżbieta Kalicińska, Monika Biernat, Justyna Rybka, et al.
Pageof 4